Citation Tools

Download PDFPDF

691 First-in-human trial of novel HBsAg-specific TCR T cell therapy (SCG101) in patients with HBV-related hepatocellular carcinoma

Download to a citation manager

Cite this article as:
Wan X, Wu W, Liu Y, et al
691 First-in-human trial of novel HBsAg-specific TCR T cell therapy (SCG101) in patients with HBV-related hepatocellular carcinoma